Mesenchymal Stem Cells; Defining the Future of Regenerative Medicine

Asieh Heirani-Tabasi, Marzieh Hassanzadeh, Shabnam Hemmati-Sadeghi, Mina Shahriyari, Mahmood Raeesolmohaddeseen

Asieh Heirani-Tabasi
ACECR-Mashhad Branch

Marzieh Hassanzadeh
Ferdowsi University of Mashhad

Shabnam Hemmati-Sadeghi
Berlin School of Regenerative Therapies (BSRT)

Mina Shahriyari
ACECR-Mashhad Branch

Mahmood Raeesolmohaddeseen
ACECR-Mashhad Branch. Email:
Online First: April 01, 2015 | Cite this Article
Heirani-Tabasi, A., Hassanzadeh, M., Hemmati-Sadeghi, S., Shahriyari, M., Raeesolmohaddeseen, M. 2015. Mesenchymal Stem Cells; Defining the Future of Regenerative Medicine. Journal of Genes and Cells 1(1-2): 34-39. DOI:10.15562/gnc.15

Cell therapy has been considered as the third pillar of medicine. There are several kinds of cells attracted researchers attention whereas the growing interest in mesenchymal stem cells (MSCs) for regenerative purposes has enabled them to explore the versatile characteristics for regenerative purposes. So far, near about 5000 clinical trials using MSCs, authenticating the clinical applicability of these cells. Their multipotent differentiation and unique immunosuppressive properties have made them ideal candidate in cell therapeutic approaches. Recent advances have been observed in the homing of these cells to enhance their transplantation efficacy. These cells have been proposed as the ideal candidates for cancer therapy and have been engineered for targeted cancer therapy. Their successful applications and responses have termed them the ideal cells for the future of regenerative medicine.            

No Supplementary Material available for this article.
Article Views      : 2244
PDF Downloads : 600